Close Menu

NEW YORK (GenomeWeb) – OpGen announced after the close of the market Wednesday that it will effect a 1-for-25 reverse stock split of its common shares.

The company said that it anticipates its common stock to trade on a split-adjusted basis under ticker symbol "OPGN" at the start of trading on Jan. 19. Also, the warrants to purchase shares of OpGen's common stock issued as part of its initial public offering will trade on a split-adjusted basis under ticker symbol "OPGNW" at the start of trading on the same day.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.